Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
HMR SELDANE FAMILY TO BE DISCONTINUED FEB. 1 FOLLOWING APPROVAL OF SELDANE D SUCCESSOR ALLEGRA D; HMR WILL NOT WITHDRAW TERFENADINE NDA
Jan 05 1998
•
By
The Pink Sheet
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Archive
More from Pink Sheet